These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 7540552

  • 1. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.
    Benzing WC, Mufson EJ.
    Exp Neurol; 1995 Apr; 132(2):162-71. PubMed ID: 7540552
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE.
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
    Kondratick CM, Vandré DD.
    J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
    [Abstract] [Full Text] [Related]

  • 8. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC, Schneider A, Mandelkow EM, Hyman BT.
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Iqbal IG, Winblad B, Pei JJ.
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW.
    Gerontology; 1997 Aug; 43 Suppl 1():16-23. PubMed ID: 9187935
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
    Gómez-Ramos P, Mufson EJ, Morán MA.
    Microsc Res Tech; 2001 Oct 01; 55(1):48-58. PubMed ID: 11596149
    [Abstract] [Full Text] [Related]

  • 18. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.
    Thangavel R, Sahu SK, Van Hoesen GW, Zaheer A.
    Neuroscience; 2009 May 05; 160(2):427-33. PubMed ID: 19250962
    [Abstract] [Full Text] [Related]

  • 19. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
    Grinberg LT, Rüb U, Ferretti RE, Nitrini R, Farfel JM, Polichiso L, Gierga K, Jacob-Filho W, Heinsen H, Brazilian Brain Bank Study Group.
    Neuropathol Appl Neurobiol; 2009 Aug 05; 35(4):406-16. PubMed ID: 19508444
    [Abstract] [Full Text] [Related]

  • 20. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW, Lee VM, Trojanowski JQ.
    Histol Histopathol; 1995 Oct 05; 10(4):969-78. PubMed ID: 8574016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.